Tuesday, 26 February 2019

Sanofi, Regeneron lose U.S. patent challenge to Amgen cholesterol drug

By Jan Wolfe (Reuters) - Biotech company Amgen Inc said on Monday a U.S.

from Latest News World on Firstpost https://ift.tt/2Tkvrsw
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)